Book contents
- Early PregnancySecond Edition
- Early Pregnancy
- Copyright page
- Contents
- Contributors
- Preface to the Second Edition
- 1 Endometrial Development and Gene Expression
- 2 Decidualization and Recurrent Miscarriage
- 3 Hemochorial Development
- 4 Implantation
- 5 Early Placental Development and Disorders
- 6 Meiosis and the Embryo
- 7 Environmental Toxicants and Reproduction
- 8 Thyroid Physiology and Early Pregnancy
- 9 Müllerian Duct Development
- 10 Candidate Genes for Pregnancy Loss
- 11 Antiphospholipid Antibodies and Reproduction
- 12 Defining Recurrent Pregnancy Loss
- 13 Guidelines on the Diagnosis and Management of Miscarriage
- 14 The Value of Early Pregnancy Units
- 15 Investigation of Recurrent Miscarriage
- 16 Designing and Optimizing Treatment Trials for Recurrent Pregnancy Loss
- 17 Risk Factors for First Trimester Miscarriage
- 18 Tubal Ectopic Pregnancy and Pregnancy of Unknown Location
- 19 Non-Tubal Ectopic Pregnancy
- 20 Ultrasound to Diagnose and Predict Early Pregnancy Outcome
- 21 Three-Dimensional Virtual Reality in Early Pregnancy
- 22 Molar Pregnancy
- 23 Role of Miscarriage Evaluation
- 24 Inherited Thrombophilia and Early Pregnancy
- 25 Immunotherapy and Recurrent Pregnancy Loss
- 26 Progesterone Use in Early Pregnancy
- 27 Vanishing Twin Syndrome and Long-Term Outcome
- 28 Obesity and Early Pregnancy
- 29 Chronic Endometritis and Reproduction
- 30 Miscarriage after In Vitro Fertilization (IVF)
- 31 HLA Associations and Recurrent Pregnancy Loss
- 32 Midtrimester Pregnancy Loss
- Index
- Plate Section (PDF Only)
- References
26 - Progesterone Use in Early Pregnancy
Published online by Cambridge University Press: 16 February 2017
Book contents
- Early PregnancySecond Edition
- Early Pregnancy
- Copyright page
- Contents
- Contributors
- Preface to the Second Edition
- 1 Endometrial Development and Gene Expression
- 2 Decidualization and Recurrent Miscarriage
- 3 Hemochorial Development
- 4 Implantation
- 5 Early Placental Development and Disorders
- 6 Meiosis and the Embryo
- 7 Environmental Toxicants and Reproduction
- 8 Thyroid Physiology and Early Pregnancy
- 9 Müllerian Duct Development
- 10 Candidate Genes for Pregnancy Loss
- 11 Antiphospholipid Antibodies and Reproduction
- 12 Defining Recurrent Pregnancy Loss
- 13 Guidelines on the Diagnosis and Management of Miscarriage
- 14 The Value of Early Pregnancy Units
- 15 Investigation of Recurrent Miscarriage
- 16 Designing and Optimizing Treatment Trials for Recurrent Pregnancy Loss
- 17 Risk Factors for First Trimester Miscarriage
- 18 Tubal Ectopic Pregnancy and Pregnancy of Unknown Location
- 19 Non-Tubal Ectopic Pregnancy
- 20 Ultrasound to Diagnose and Predict Early Pregnancy Outcome
- 21 Three-Dimensional Virtual Reality in Early Pregnancy
- 22 Molar Pregnancy
- 23 Role of Miscarriage Evaluation
- 24 Inherited Thrombophilia and Early Pregnancy
- 25 Immunotherapy and Recurrent Pregnancy Loss
- 26 Progesterone Use in Early Pregnancy
- 27 Vanishing Twin Syndrome and Long-Term Outcome
- 28 Obesity and Early Pregnancy
- 29 Chronic Endometritis and Reproduction
- 30 Miscarriage after In Vitro Fertilization (IVF)
- 31 HLA Associations and Recurrent Pregnancy Loss
- 32 Midtrimester Pregnancy Loss
- Index
- Plate Section (PDF Only)
- References
- Type
- Chapter
- Information
- Early Pregnancy , pp. 256 - 261Publisher: Cambridge University PressPrint publication year: 2017
References
Conneely, O. M., Mulac-Jericevic, B., DeMayo, F., Lydon, J. P., O'Malley, B. W. (2002). Reproductive functions of progesterone receptors. Recent Progress in Hormone Research, 57, 339–55.CrossRefGoogle ScholarPubMed
Gellersen, B., Fernandes, M. S., Brosens, J. J. (2009). Non-genomic progesterone actions in female reproduction. Human Reproduction Update, 15(1), 119–38.Google ScholarPubMed
Mulac-Jericevic, B., Mullinax, R. A, DeMayo, F. J., Lydon, J. P., Conneely, O. M. (2000). Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science (New York, N.Y.), 289(5485), 1751–54.CrossRefGoogle ScholarPubMed
Zakar, T., Hertelendy, F. (2007). Progesterone withdrawal: key to parturition. American Journal of Obstetrics and Gynecology, 196, 289–96.CrossRefGoogle ScholarPubMed
Zakar, T., Mesiano, S. (2011). How does progesterone relax the uterus in pregnancy? The New England Journal of Medicine, 364(10), 972–73.CrossRefGoogle ScholarPubMed
Druckmann, R., Druckmann, M. A. (2005). Progesterone and the immunology of pregnancy. Journal of Steroid Biochemistry and Molecular Biology, 97(5), 389–96.CrossRefGoogle ScholarPubMed
Lissauer, D., Eldershaw, S. A., Inman, C. F., Coomarasamy, A., Moss, P. A. H., Kilby, M. D. (2015). Progesterone promotes maternal–fetal tolerance by reducing human maternal T-cell polyfunctionality and inducing a specific cytokine profile. European Journal of Immunology, 45, 2858–2872.CrossRefGoogle ScholarPubMed
Csapo, A. I., Pulkkinen, M. O., Kaihola, H. L. (1973). The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus. Prostaglandins, 4(3), 421–49.CrossRefGoogle ScholarPubMed
Filicori, M., Butler, J.P,. Crowley, W.F. Jr. (1984). Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. Journal of Clinical Investigation, 73, 1638–47.CrossRefGoogle ScholarPubMed
Jordan, J., Craig, K., Clifton, D.K., Soules, M.R. Luteal phase deficiency: the sensitivity and specificity of diagnostic methods in common clinical use (1994). Fertility & Sterility, 62, 54–62.CrossRefGoogle Scholar
Verhaegen, J., Gallos, I. D., van Mello, N. M., Abdel-Aziz, M., Takwoingi, Y., Harb, H., et al. (2012). Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ, 345, e6077.CrossRefGoogle ScholarPubMed
Coomarasamy, A., Williams, H., Truchanowicz, E., Seed, P. T., Small, R., Quenby, S., et al. (2015). A randomized trial of progesterone in women with recurrent miscarriages. New England Journal of Medicine, 373(22), 2141–48.CrossRefGoogle ScholarPubMed
Frost, J., Bradley, H., Levitas, R., Smith, L., Garcia, J. (2007). The loss of possibility: scientisation of death and the special case of early miscarriage. Sociology of Health and Illness, 29 (7), 1003–22.CrossRefGoogle ScholarPubMed
Ehrenskjold, ML, Bondo, B, Weile, F (1967). [Treatment of threatened abortion with dydrogesterone]. Ugeskr Laeger Dec, 14, 129(50), 1678–79.Google Scholar
El-Zibdeh, M.Y., Yousef, L.T. (2009). Dydrogesterone support in threatened miscarriage. Maturitas, 65 (Dec)(Suppl 1), S43–46.CrossRefGoogle ScholarPubMed
Gerhard, I., Gwinner, B., Eggert-Kruse, W., Runnebaum, B. (1987). Double-blind controlled trial of progesterone substitution in threatened abortion. Biol Res Pregnancy Perinatol, 8, 26–34.Google ScholarPubMed
Misto, A. (1967). Experiences with 6-dehydro-retroprogesterone int the treatment of placental insufficiency. Ann Ostet Ginecol Med Perinat, 89 (2), 102–12.Google ScholarPubMed
Omar, M.H., Mashita, M.K., Lim, P.S., Jamil, M.A. (2005). Dydrogesterone in threatened abortion: pregnancy outcome. The Journal of Steroid Biochemistry and Molecular Biology, 97(5), 421–45.CrossRefGoogle ScholarPubMed
Palagiano, A., Bulletti, C., Pace, M.C., Zeigler, D.E., Cicinelli, E., Izzo, A. (2004). Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Ann N Y Acad Sci, 1034 (Dec), 200–10.CrossRefGoogle ScholarPubMed
Pandian, R.U. (2009). Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas, 65 (Suppl 1), S47–50.CrossRefGoogle ScholarPubMed
Humaidan, P., Papanikolaou, E. G., Kyrou, D., Alsbjerg, B., Polyzos, N. P., Devroey, P., et al. (2012). The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reproductive Biomedicine Online, 24(2), 134–41.CrossRefGoogle ScholarPubMed
Miyake., A., Aono,. T., Kinugasa, T., Tanizawa, O., Kurachi, K. (1979). Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women. J Endocrinol, 80, 353–56.CrossRefGoogle Scholar
Bourgain, C., Devroey, P., Van Waesberghe, L., Smitz, J., Van Steirteghem, A.C. (1990). Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod, 5, 537–43.CrossRefGoogle ScholarPubMed
Kolibianakis, E.M., Devroey, P. (2002). The luteal phase after ovarian stimulation. Reproductive Biomedicine Online, 5(Suppl 1), 26–35.CrossRefGoogle ScholarPubMed
van der Linden, M., Buckingham, K., Farquhar, C., Kremer, J.A.M., Metwally, M. (2015). Luteal phase support for assisted reproduction cycles. Cochrane Database of Systematic Reviews, Issue 7, CD009154.CrossRefGoogle Scholar
Pritts, E.A., Atwood, A.K. (2002). Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod,17, 2287–99.CrossRefGoogle ScholarPubMed
Daya, S., Gunby, J. (2004). Luteal phase support in assisted reproduction cycles. Cochrane Database of Systematic Reviews, Issue 3, CD004830.CrossRefGoogle Scholar
Kumar, A., Begum, N., Prasad, S., Aggarwal, S., Sharma, S. (2014). Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertility and Sterility, 102(5), 1357–1363.e3.CrossRefGoogle ScholarPubMed